COBALT REHAB HOSPITAL SURPRISE — History
CCN 033039 | 3-year financial timeline | COVID resilience: 36/100
🛡️ Public data only — no PHI permitted on this instance.
$15M
Latest Revenue (FY2022)
+2.4%
Revenue CAGR (3yr)
6.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $14M | $11M | $15M | +30.8% | +2.4% |
| Operating Expenses | $10M | $13M | $14M | +10.1% | +15.9% |
| Operating Margin | 26.7% | -11.6% | 6.1% | +152.2% | -52.4% |
| Net Income | $4M | $-1M | $1M | +168.3% | -51.3% |
| Licensed Beds | 40 | 40 | 40 | +0.0% | +0.0% |
| Total Patient Days | 9,029 | 7,510 | 8,709 | +16.0% | -1.8% |
| Medicare Day % | 54% | 52% | 49% | -4.3% | -4.7% |
| Medicaid Day % | 1% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 36/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: +4.8% ($14M → $15M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+2.4%
This Hospital
+7.6%
State Avg
Latest Margin
6.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $15M | -4.3% |
| FY2024 (proj) | $16M | -14.6% |
| FY2025 (proj) | $16M | -25.0% |